InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by A2A Pharmaceuticals, Inc.. Officer active across 1 company, notably Biomea Fusion, Inc.. Aggregated, 3 filings have been logged. Split: 2 buys · 1 sell. Total volume traded: €1m. History available since 17 September 2021. The latest transaction was filed on 24 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
34,658 shares@ US$11.760.40% mcap37.5% of flowCommon StockSEC:0001856641-22-000001:0
34,658 shares@ US$10.960.33% mcap31.2% of flowCommon StockSEC:0000899243-21-036769:0
Ideal exit: 14 Jun 2022 (T+270)
34,658 shares@ US$10.96100.0% of flowCommon StockSEC:0000899243-21-036769
Ideal exit: 14 Jun 2022 (T+270)
3 of 3 declarations
